A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants
This study demonstrated no significant differences in complication rates for CAT patients treated with DOAC s over enoxaparin, suggesting that DOACs can be safely used in most cases of CAT.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Coumadin | Hematology | Lovenox | Oral Cancer | Study | Thrombosis | Warfarin